BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

790 related articles for article (PubMed ID: 26647384)

  • 1. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.
    Rafehi S; Ramos Valdes Y; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
    Endocr Relat Cancer; 2016 Mar; 23(3):147-59. PubMed ID: 26647384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch and TGFβ form a positive regulatory loop and regulate EMT in epithelial ovarian cancer cells.
    Zhou J; Jain S; Azad AK; Xu X; Yu HC; Xu Z; Godbout R; Fu Y
    Cell Signal; 2016 Aug; 28(8):838-49. PubMed ID: 27075926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma.
    Du J; Sun B; Zhao X; Gu Q; Dong X; Mo J; Sun T; Wang J; Sun R; Liu Y
    Gynecol Oncol; 2014 Jun; 133(3):575-83. PubMed ID: 24589413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
    Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
    Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMP signalling controls the malignant potential of ascites-derived human epithelial ovarian cancer spheroids via AKT kinase activation.
    Peart TM; Correa RJ; Valdes YR; Dimattia GE; Shepherd TG
    Clin Exp Metastasis; 2012 Apr; 29(4):293-313. PubMed ID: 22249415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
    Norita R; Suzuki Y; Furutani Y; Takahashi K; Yoshimatsu Y; Podyma-Inoue KA; Watabe T; Sato Y
    Cancer Sci; 2017 Mar; 108(3):419-426. PubMed ID: 28064471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusions.
    Elloul S; Vaksman O; Stavnes HT; Trope CG; Davidson B; Reich R
    Clin Exp Metastasis; 2010 Mar; 27(3):161-72. PubMed ID: 20213325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditioned media from human ovarian cancer endothelial progenitor cells induces ovarian cancer cell migration by activating epithelial-to-mesenchymal transition.
    Teng L; Peng S; Guo H; Liang H; Xu Z; Su Y; Gao L
    Cancer Gene Ther; 2015 Nov; 22(11):518-23. PubMed ID: 26494557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions.
    Matte I; Legault CM; Garde-Granger P; Laplante C; Bessette P; Rancourt C; Piché A
    Clin Exp Metastasis; 2016 Dec; 33(8):839-852. PubMed ID: 27612856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An mDia2/ROCK signaling axis regulates invasive egress from epithelial ovarian cancer spheroids.
    Pettee KM; Dvorak KM; Nestor-Kalinoski AL; Eisenmann KM
    PLoS One; 2014; 9(2):e90371. PubMed ID: 24587343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
    Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J
    Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel network integrating a miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition.
    Moes M; Le Béchec A; Crespo I; Laurini C; Halavatyi A; Vetter G; Del Sol A; Friederich E
    PLoS One; 2012; 7(4):e35440. PubMed ID: 22514743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Heat Shock Transcription Factor HSF1 Induces Ovarian Cancer Epithelial-Mesenchymal Transition in a 3D Spheroid Growth Model.
    Powell CD; Paullin TR; Aoisa C; Menzie CJ; Ubaldini A; Westerheide SD
    PLoS One; 2016; 11(12):e0168389. PubMed ID: 27997575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells.
    Rodgers JJ; McClure R; Epis MR; Cohen RJ; Leedman PJ; Harvey JM; ; Thomas MA; Bentel JM
    J Cell Biochem; 2019 Jan; 120(1):848-860. PubMed ID: 30161276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Systematic Analysis of Negative Growth Control Implicates the DREAM Complex in Cancer Cell Dormancy.
    MacDonald J; Ramos-Valdes Y; Perampalam P; Litovchick L; DiMattia GE; Dick FA
    Mol Cancer Res; 2017 Apr; 15(4):371-381. PubMed ID: 28031411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer.
    Xu Q; Sun Q; Zhang J; Yu J; Chen W; Zhang Z
    Carcinogenesis; 2013 Mar; 34(3):539-49. PubMed ID: 23188671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance.
    Davidowitz RA; Selfors LM; Iwanicki MP; Elias KM; Karst A; Piao H; Ince TA; Drage MG; Dering J; Konecny GE; Matulonis U; Mills GB; Slamon DJ; Drapkin R; Brugge JS
    J Clin Invest; 2014 Jun; 124(6):2611-25. PubMed ID: 24762435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids.
    Correa RJ; Peart T; Valdes YR; DiMattia GE; Shepherd TG
    Carcinogenesis; 2012 Jan; 33(1):49-58. PubMed ID: 22045027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGFβ and EGF synergistically induce a more invasive phenotype of epithelial ovarian cancer cells.
    Xu Z; Jiang Y; Steed H; Davidge S; Fu Y
    Biochem Biophys Res Commun; 2010 Oct; 401(3):376-81. PubMed ID: 20854793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile.
    Latifi A; Abubaker K; Castrechini N; Ward AC; Liongue C; Dobill F; Kumar J; Thompson EW; Quinn MA; Findlay JK; Ahmed N
    J Cell Biochem; 2011 Oct; 112(10):2850-64. PubMed ID: 21618587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.